Neo Ivy Capital Management Medtronic PLC Transaction History

Neo Ivy Capital Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$79.47 - $91.38 $52,211 - $60,036	657 New	657 $57,000
Q2 2022 Aug 16, 2022	SELL	$87.4 - $113.09 $131,012 - $169,521	-1,499 Reduced 52.89%	1,335 $119,000
Q1 2022 May 16, 2022	SELL	$100.58 - $112.38 $222,281 - $248,359	-2,210 Reduced 43.81%	2,834 $314,000
Q4 2021 Feb 15, 2022	SELL	$99.53 - $127.75 $83,605 - $107,310	-840 Reduced 14.28%	5,044 $521,000
Q3 2021 Nov 16, 2021	BUY	$122.75 - $135.17 $273,732 - $301,429	2,230 Added 61.03%	5,884 $540,000
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $379,626 - $422,378	3,212 Added 726.7%	3,654 $454,000
Q1 2021 Oct 07, 2021	BUY	$111.18 - $119.74 $49,141 - $52,925	442 New	442 $52,000
Q3 2020 Nov 17, 2020	SELL	$90.13 - $108.78 $1.34 Million - $1.61 Million	-14,834 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$84.11 - $103.33 $752,784 - $924,803	8,950 Added 152.11%	14,834 $1.36 Million
Q2 2020 Aug 17, 2020	BUY	$84.11 - $103.33 $420,970 - $517,166	5,005 Added 569.4%	5,884 $540,000
Q1 2020 May 15, 2020	SELL	$72.92 - $121.3 $76,274 - $126,879	-1,046 Reduced 54.34%	879 $79,000
Q4 2019 Feb 13, 2020	BUY	$104.49 - $114.54 $201,143 - $220,489	1,925 New	1,925 $218,000
Q3 2019 Nov 21, 2019	SELL	$98.02 - $111.18 $1.45 Million - $1.65 Million	-14,834 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$84.15 - $99.38 $82,803 - $97,789	-984 Reduced 6.22%	14,834 $1.45 Million
Q1 2019 May 15, 2019	BUY	$82.45 - $93.79 $1.3 Million - $1.48 Million	15,818 New	15,818 $1.44 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.